#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Homocystinuria Neurotrophic keratopathy Fibrosarcoma metastatic Pancreatic carcinoma Peritoneal neoplasm Systemic lupus erythematosus Adenocarcinoma pancreas High-grade B-cell lymphoma Spinal cord injury Cerebral amyloid angiopathy Penile cancer Malignant glioma Erythema multiforme Hyperchylomicronaemia Immune-mediated myasthenia gravis More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Basic Information Mantle cell lymphoma refractory – Basic Information Hereditary optic atrophy Primary immunodeficiency syndrome Angiosarcoma – Life with Disease Combined immunodeficiency – Treatment Brain stem glioma – Trials in Disease Ehlers-Danlos syndrome – Diagnostics Atypical teratoid/rhabdoid tumour of CNS – Treatment Bronchopulmonary dysplasia More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lamivudine Gilteritinib Aptamer-4Ft Poa Pratensis Pollen Extract Ro7247669 Alizapride Ngm707 L-Histidine Dobutamine Anselamimab Art6043 Arrhenatherum Elatius Bgb-15025 Citrate Dapansutrile Acp-204 Tartrate Rbd5044 Sodium Vinblastine Sulfate Cabozantinib Fremanezumab Dnth103 More therapies…

    Learn about Your Condition

    Metastases to liver Peritonitis Deafness traumatic Poor quality sleep Bladder cancer Growth hormone deficiency Malignant melanoma stage IV Glycogen storage disorder Conjunctivitis allergic Decreased appetite Juvenile psoriatic arthritis Radiation skin injury Osteochondrodysplasia Lymphoedema Cervix carcinoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neoplasm
    • Non-small cell lung cancer
    Investigated Drugs:
    • Nvl-655
    Belgium France Germany Italy The Netherlands Spain

  • Study Comparing Apixaban and Warfarin for Patients with Heart Clots After a Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac ventricular thrombosis
    • Acute myocardial infarction
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Perflutren
    • Apixaban
    Denmark Sweden

  • Study on Colchicine for Patients with Knee or Hip Osteoarthritis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Colchicine
    The Netherlands

  • Study on Preventing Hepatic Encephalopathy with Rifaximin and Lactulose in Patients with Alcoholic Liver Cirrhosis Undergoing TIPS Placement

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cirrhosis alcoholic
    Investigated Drugs:
    • Lactulose
    • Rifaximin
    Belgium The Netherlands

  • Study on Sustained-Release Dexamphetamine and Piracetam for Patients with Moderate to Severe Cocaine Use Disorder and Opioid Dependence

    Recruiting

    3 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Dexamfetamine Sulfate
    • Piracetam
    The Netherlands

  • Study on Levosimendan for Treating Aneurysmal Subarachnoid Hemorrhage in Intensive Care Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Levosimendan
    France
Previous Page
1 … 401 402 403 404 405 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!